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Summary.-The leukaemic lesions in intact and ovariectomized mice of strain
ICRC, induced with 20-methylcholanthrene (20-MCA) in combination with or with-
out hormones were investigated for the presence of mouse leukaemia virus (MuLV)
by (i) bioassays and (ii) electron microscopy. The different experimental groups
treated with 20-MCA were (i) intact females, (ii) ovariectomized females, (iii)
ovariectomized females with pituitary graft, (iv) ovariectomized females with
10 jg oestradiol/day for 30 days and (v) ovariectomized females with 1 ,g oestradiol
together with 1 mg progesterone/day for 30 days. It was possible to trahismit
nearly all these experimentally induced leukaemias to syngeneic mice thtough
acellular extracts, compared with very poor transmissibility of spontaneous leuk-
aemias in the ICRC strain, indicating functional activation of viral agents on com-
bined treatment with carcinogen and hormones. Potency of the acellular leukaemic
extract from the mice of group (ii) without the ovarian hormones was much weaker
than that from mice of the other experimental groups. The leukaemogenic activity
of MuLV was enhanced on serial transmission in syngeneic hosts. Leukaemic
lesions of ovariectomized mice treated with 20-MCA and oestradiol were also trans-
missible to the sucklings of allogeneic mice of strain C3H-MTV, C57-BL and Dba-
MTV. The cell-free supernatant medium of the cultures of these leukaemic lesions
induced leukaemias on back inoculation into syngeneic mice. Electron microscopic
studies of lesions induced with carcinogen and oestradiol consistently showed
abundant intracytoplasmic type A particles. Numerous intracytoplasmic type A
particles as well as some type B particles were found in the leukaemic tissues of
ovariectomized females treated with MCA and oestradiol combined with pro-
gesterone. Type C particles, characteristic of MuLV were seen in the leukaemic
tissues of all other experimental groups. These findings indicate a significant
influence of the physiological condition of the host, particularly the hormonal make
up, on expression and activity of specific viral agents.
THE ICRC strain of mice, developed
at the Biology Division laboratories of
Cancer Research Institute, Bombay is
susceptible to the spontaneous develop-
ment of breast cancer and lymphatic
leukaemia. The presence of potent MTV
in milk and mammary tissue has been
confirmed (Ranadive et al., 1961), and
thepresence of weakMuLV in spontaneous
and transplanted leukaemia of this strain
has already been reported (Ranadive et
al., 1973). The electron microscopic
studies revealed paucity of type C virus
particles, characteristic of murine leuk-
aemia, in the spontaneous leukaemic
tissues (Hiraki, Ranadive and Dmochow-
ski, 1974). Studies on the experimental
induction of leukaemia in castrates of
this strain have confirmed the importance
of hormones in the acceleration of leuk-
aemogenesis (Karande and Ranadive,
1973). These experimentally inducedACTIVATION OF MURINE LEUKAEMIA VIRUS
leukaemic lesions have been investigated
for the presence of MuLV by bioassays
and electron microscopy. The present
communication reports these data evinc-
ing activation of the viral agent/s under
different physiological conditions.
MATERIALS AND METHODS
Younig virgin ICRC female mice from
generations 35-36 wAere used. For the
experimental induction of leukaemia, normal
intact and ovariectomized females were
given 20-methylcholanthrene (20-MCA) in
olive oil, once a week by stomach tube for
8 wN-eeks. The carcinogen treated ovariec-
tomized females were also given a daily
dose of oestradiol alone and a dose of oestra-
diol with progesterone for a period of 30
days. In another group of ovariectomized
mice, 2 pituitaries from isologous male
mice wNere grafted subcutaneously onto the
right inguinal pair of mammary glands.
The detailed experimental procedure has
been reported before (Karande and Ranadive,
1973). Extracts of leukaemic lesions wAere
prepared for viral studies from the following
groups: Group I (intact virgin mice treated
with 20-MCA (Extract I)); Group II (ovari-
ectomized mice treated with 20-MCA (Extract
II); Group II (ovariectomized mice with 2
pituitary grafts and treated with 20-MCA
(Extract III)); Group IV (ovariectomized
mice treated with 20-MCA and 10 ,tg oestra-
diol/day for 30 days (Extract IV)); Group V
(ovariectomized mice treated with 20-MCA
and 1 ,ug oestradiol X- 1 mg progesterone/day
for 30 days (Extract V)).
Preparation of acellular extracts of the
leukaemic tissues.-The acellular extracts of
the leukaemic tissues were prepared according
to Latarjet and Duplan's method (1962).
The spleen, mesenteric lymph node and
liver were pooled, minced and homogenized
in a Teflon homogenizer and suspended in
Tyrode's balanced salt solution as either
25% or 40% (w/v) extract. For the initial
passages, the leukaemic tissues from the
mice with the shortest latent period were
used for viral preparation. In the subse-
quent passages, the transplanted leukaemic
lesions from the same passage were pooled
together for inoculations. The suspension
was centrifuged at 2000 g for 20 min at
4 C in the International Centrifuge model
HR-1. The supernatant w\vas removed and
centrifuged again at 12,000 g for 20 min.
The upper 2/3rd portion of the clear super-
natant fluid wras injected intraperitoneally
int,o sucklings (0-2 ml/mouse) or weanlings
(0.5 ml/mouse) of syngeneic or allogeneic
mice. Since the mortality in the newA born
mice which received leukaemic extracts wsas
rather high, sucklings more than 4 days old
were used for the inoculations. Absence of
intact cells from this extract w\Aas verified
by staining smears of the extract. The
allogeneic recipients were from strains
ICRC-MTV, Dba-MTV, C3H-MTV, Strong A
and C57-BL.
Preparation of high centrifugal pellet of the
leukaemic tissues. The leukaemic tissues
were minced, homogenized in a Teflon
homogenizer and 25% (w/v) extract was
prepared in Tyrode's balanced salt solution.
The suspension was then centrifuged at
2000 g and 12,000 g for 20 min each at
4°C. A final centrifugation was done at
98,000 g for 90 min. The pellet was then
suspended in Tyrode's balanced salt solution
and injected intraperitoneally into sucklings
of various strains of mice.
In vitro cultivation of leukaemnic lesions.-
The leukaemic lesions were cultivated in
vitro as static suspension cultures (Imagawa
et at., 1968). The medium consisted of
BME with a 4 times greater concentration
of vitamins and amino acids than usual
(Eagle, 1955) supplemented with 15% horse
serum. The cultures were incubated at
37°C in an atmosphere of 5% CO2 and
9500 air. They wvere fed with fresh medium
on every fourth day, retaining 1 ml of the
previous culture medium. Acellular extract,
as well as the high centrifugal pellet of the
cell free supernatant culture medium were
prepared as described above and inoculated
into w-eanlings of syngeneic mice.
Light and electron microscopy. The leu-
kaemic tissues (liver, spleen, thymus, kidneys
and lymph nodes) were fixed in Zenker-
formol for light microscopy. Tissues for
electron microscopy w%ere fixed in 6.25%
glutaraldehyde for 1 to 1 h, post-fixed in
10% osmium tetroxide in Sorensen's buffer,
dehydrated in ethanol solutions and em-
bedded in Araldite. The sections were cut
on a Porter-5-Blum MT 2 Sorval ultra-
microtome, stained in uranyl acetate followed
by lead citrate and examined in a Siemens
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Elmiskop IA and a RCA EMU G electroni
microscope*.
RESULTS
The strain 1CRC is at present in the
40th generation of inbreeding. The in-
cidence of leuikaemia in virgins and
breeders of each generation has been
studied. The average incidence of leuk-
aemia in the generations F6 to F10 was
42.80%; Fllth to F20th, 27.0% and
F21st to F30th, 13.9%. The incidence
of leukaemia in generations F34-F35,
of whichtheanimalshavebeen usedfor the
present study, was 14.6 o.
Cellular transnission of experimentally
induced ICRC leukaemina
All the leukaemic lesions from the
experimental groups II, III, IV and V
were kept in serial transmission in syn-
geneic mice without any difficuilty, with
the exception of those from Group I.
Approximately 5 x I07 cells were injected
intraperitoneally in young adult mice.
The latent period, which was 1-2 months
for the initial 2-3 passages, was reduced
to 8 days subsequently.
Leukaemogenic activity of acellular extracts
of lesions induced with 20-MICA in intact
and ovariectomized mice
The leukaemia incidence in intact and
ovariectomized ICRC females treated with
20-MCA was 46.1% and 34.40o respect-
ively. About 76% intact females treated
with carcinogen, developed mammary
cancer as well as leukaemia (Karande and
Ranadive, 1973).
On inoculation of extract I (intact
virgins treated with 20-MCA) in weanlings
of ICRC mice, only one out of 8 animals
developed leukaemia in the first passage
with a latent period of 160 days (Table I).
In further serial passages, the leukaemia
incidence increased to 100% with a latent
period ranging between 35 and 45 days.
TABLE I.-Leutkaemogenic Activity ofAcel-
litlar Extracts of 20-MCA Induced
Leukaemia in Intact and Ovarietomized
JCRC Females
No. of
No. of animals
Serial animals with
pas- inoculated leukaemia
Leukaemic sage
extract No. c
Extract I 1 4 4 - 1
2 2 4 1 4
3 _-- 6 - 3
4 6 3 6 3
(100%)
*5 5 8 5 8
(100%)
Extract II 1 5 3 1 1
2 4 2
Latent
period
(days)
160
39-50
48-65
35-45
30-40
130-300
* The leukaemia is in the 18th passage of serial
transmission at present with the latent period of
30-35 days in 1000% recipients.
This lesion is at present in its 18th
passage of serial transmission. With ex-
tract II (ovariectomized females treated
with 20-MCA) it was possible to induce
leukaemia in 2 out of 8 first passage
recipients with a latent period between
130 and 300 days. Further serial trans-
mission was not possible, indicating there-
by the low potency of the MuLV. Elec-
tron microscopy of the leukaemic tissues
of both the primary lesions from which
extract I and II were prepared showed
few type C particles and intracisternal
type A particles (Table VI).
Leukaernogenic activity of acellular extracts
of lesions induced with 20-llICA and
pituitary graft
The data for extract III are shown in
Table II. The incidence of leukaemia
in ovariectomized ICRC mice treated
with 20-MCA along with pituitary graft
was 64-7%o. The leukaemic lesion used
for serial transmission was developed
after 3 months ofexperimental treatment.
In the first passage, 4 animals out of
a total number of 17 developed leukaemia
* The election microscopic studies were carried out by oie of the authors (KJR) in collaboration with
Di-s Hiraki anid Dmochowski during her stay as Visiting Professor of Virology at the Department of
Virology, M. D. Ander-son Hospital and Tumor Instituite, University of Texas, Houston, Texas, U.S.A.
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TABLE II. Serial TransMission ofLeukaemia Induced in Ovariectornized ICRC Females
with 20-MCA and Pituitary Graft (Extract III)
Syngenteic mice
No. of
animals
No. of
animals c
leukaemia
inioculate(d Latent
Jssage ,- y c period
no. $ c3 (incidence) ((lays)
1 8 9 1 3 170, 240,
245, 270
2 4 4 2 1 42, 70,
95
3 4 2 4 2 40-65
4
5
6
(40%)
7
(40 %)
3
1
4
4
7
4
(100%)
1
1 4
(62 5%)
I
47
33-53
52
Allogeneic mice
Material
inoculate(d
40% Acellular
extract
(passage 3)
Strain
and no. of
animals
inoculated
ICRC-MITV'
8
Dba-MTV
5
C57-1B1
7
Age of
animals
at the
time of
inoculation
(days)
Incidenice
of
leiukaemia
11
10
9'
5 5 1
(10%)
with alatent period ofbetween 170 and 270
days. The incidence was 100% in the
third passage and the latent period was
reduced to 40-65 days. From the sixth
passage onwards 4000 acellular extract
was used for inoculation instead of 25%.
Even then the incidence of leukaemia
was only between 10 and 12 with a
latent period of 52-55 days. This line
was eventually lost after the 7th serial
passage in syngeneic mice. Attempts
to transmit this leukaemia in sucklings
of allogeneic mice such as ICRC-MTV7,
Dba-MTV and C57-BL have failed.
The electron microscopic studies car-
ried out on the leukaemic tissues of
primary as well as transmitted lesions
have demonstrated few or occasional
type C particles, invariably accompanied
by intracisternal type A particles (Table
VI).
Leukaemogenic activity of acellular extracts
of lesions indtced with carcinogen and
oestradiol
The data on extract IV are tabulated
in Tables III and IV. The incidence
of leukaemia in ovariectomized ICRC
females treated with 20-MCA and oestra-
diol was 81*2%. About 12-5% females
developed mammary cancer. One female
TABLE III. Serial Transmission of Leuk-
aemia Originally Induced in Ovariec-
tomized ICRC Females with 20-31CA
and Oestradiol, in Syngeneic MIice (Ex-
tract IV)
Passage
no.
1
2
3
4
5
6
7
*8
(40% extIract)
No. of
animals
inoculated
y
6-
7 4
7
5
5
9
3
6
3
No. of
animals
with
letukaemia
3
6 4
5 3
(100/)
6 5
(84 6%)
5 3
(100%)
2 1
(42 8%)
1
(16.6 0)
9
(100%)
Laten-t period
(days)
65, 240, 240
40
38-40
34 70
29-60
40-50
55
34-36
* The leukaemia is in the 20th passage of serial
tiransmission at present with the latent period of
30-40 clays in 100% recipients.
developed mammary cancer as well as
leukaemia.
On inoculation of the leukaemic ex-
tract in syngeneic mice, the incidence of
leukaemia in the first passage was 5000,
with the latent period ranging between
Pa
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TABLE IV.-Serial Transmission of Leukaemia Originally Induced in Ovariectomized
ICRC Females with 20-MCA and Oestradiol, in Allogeneic Mice (Extract IV)
Leukaemic
extract
Extract IV
(Passage 4)
Material
inoculated
Acellular extract
(40%
homogenate)
Extract IV High centrifugal
pellet
Total no.
of animals
inoculated
18
36
Strain and no.
of animals
inoculated
ICRC-MTV
5
Dba-MTV
3
Strong A
3
C3H Jax
2
*C3H-MTV
5
ICRC
5
ICRl-MTV
12
tDba-MTV
5
Strong A
6
tC57-BL
6
C3H-Jax
2
Age of animals
at the time of
inoculation
(days)
6
7
7
6
8
6
6
21
5
14
6
8
8
4
Incidence of
leukaemia
3/5
2/3
1/5
3/5
3/6
3/5 111, 150
150
1/6 82
* The line is in 2nd passage of transmission in syngeneic mice.
t The line is in 4th passage of transmission in syngeneic mice.
I The line is in 4th passage of transmission in syngeneic mice.
65 and 240 days. By the third passage,
all the inoculated mice developed leuk-
aemia, the latent period being reduced
to 38-40 days. As there was a gradual
decrease in the leukaemia incidence in
the subsequent passages, 40% acellular
extract instead of 25% was used for
further inoculations. This resulted in
increased incidence (100%) with a latent
period of 34-36 days. This leukaemic
lesion designated as " IE2 " has been
consistently transmissible through acel-
lular extracts and is at present in its
20th passage of serial transmission.
Transmission of leukaemia in allogeneic
mice
The data have been presented in
Table IV. Leukaemic tissues from a
batch of animals in the same passage were
pooled and either 40% acellular extract
or high centrifugal pellet was prepared.
The acellular MuLV preparations were
inoculated into the sucklings of allogeneic
strains. It was possible to transmit the
leukaemia in sucklings of allogeneic hosts
such as ICRC-MTV, Dba-MTV, C57-
BL and C3H-MTV, the strains devoid
of mammary tumour virus. After inocu-
lation of 40% acellular extract of the
leukaemic tissues, 2 out of 3 Dba-MTV
animals, 3 out of 5 ICRC-MTV animals
and one out of 5 C3H-MTV animals
developed leukaemia with the latent
period comparable with that in the
parent line. The inoculations were done
at the ages between 6 and 8 days. Strains
Strong A and C3H(Jax) having potent
MTV have not yet developed leukaemia,
the animals at present being 355 and 270
days old respectively.
With the inoculation of high centri-
fugal pellet of the leukaemic tissue ex-
tract, it was possible to transmit the
leukaemia in strain C57-BL suckling mice.
One out of a total of 6 inoculated
Latent
period
(days)
43-45
45, 85
36
45, 51
66
44
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mice developed leukaemia with a latent
period of 82 days. In strain ICRC-
MTV, one out of 6 inoculated mice
developed leukaemia when the animals
were injected at the age of 5 days. The
group of ICRC-MTV animals, inoculated
at the age of 14 days, did not develop
leukaemia, indicating the importance of
age at the time of inoculation in the
development of the disease. Attempts
were also made to transmit the induced
lesions of strains Dba-MTV, C3H-MTV
and C57BL in the respective syngeneic
mice (Table IV). At present the leu-
kaemic lesions are in 4th, 2nd and 4th
serial passages of transmission in strain
Dba-MTV, C3H-MTV and C57-BL
respectively.
Electron microscopic studies carried
out on the tissues of primary leukaemia
lesions as well as subsequent passages
of strain ICRC mice revealed the absence
of type C particles characteristic of
murine leukaemia virus. On the other
hand, almost all the tissues studied pre-
sented an abundance of intracytoplasmic
type A virus particles consistently. The
E.M. studies carried out on some of the
leukaemic lesions of strains Dba-MTV
and C57-BL also showed an abundance
of intracytoplasmic A particles similar
to those observed in the parent line.
In vitro studies
Three out of 5 animals inoculated
with high centrifugal pellet of the cell-
free supernatant culture medium of leu-
kaemic spleens of this IE2 line developed
leukaemia within the latent period of 2-7
months.
Leukaemogenic activity of acellular extracts
of lesions induced with carcinogen together
with oestradiol and progesterone
The data on extract V are tabulated
in Table V. The incidence of leukaemia
in ovariectomized ICRC females treated
with 20-MCA along with oestradiol and
progesterone was 73-3o. The mammary
cancer incidence in this group was 400/,.
TABLE V. Serial Transmission of Leuk-
aenmia Induced in Ovariectomized ICRC
Females with 20-MC(A alony with Oestra-
diol and Progesterone (Extract VT)
Pa,,ssage
No. of animals No. of animals
iniocuilate(d with leukaemia,
rio. V IS V
1 6 8 4 :1
(50%)
2 5 5 3 2
(50%)
3 4 6 1 l
(20 %)
Latetit
period1
180-240
90-120
90
About 4500 leukaemic females also de-
veloped mammary cancer.
On inoculation of acellular extract of
these leukaemic lesions, 5000 syngeneic
recipients of the first passage developed
leukaemia with the latent period ranging
between 180 and 240 days. In the third
passage, about 20% animals developed
leukaemia with an average latent period
of 90 days. This line was ultimately lost
after the 4th serial passage. Electron
microscopic studies carried ouit on some
of the leukaemia lesions showed an
abundance of intracytoplasmic A particles
with complete absence of type C particles.
Type B particles were occasionally ob-
served in some of the leukaemic spleens.
D1ISCrSSION
The role of hormones in accelerating
leukaemogenesis in strain ICRC has been
studied previously (Karande and Rana-
dive, 1973). Treatment with chemical
carcinogens accelerated the process of
leukaemogenesis in castrated ICRC mice,
particularly when the carcinogen was
administered together with the hormones.
This demonstrated the importance of the
physiological environment of the host
in controlling oncogene activation. The
possibility that the hormonal stattus during
the life span of the host is influential in
both the repression and derepression
of the oncogene has been stiggested
recently by Hellman and Fowler (1971).
The successful isolation of a filterable
MIuLV' from chemically iinduiced lvympho-
439K. A. KARANDE, S. P. TASKAR AND K. J. RANADIVE
TABLE VI. Electron microscopic Observations on the Lemkaernic Tissues of Primary and
Transplanted Lesions
Experimental serieiS
Castrates +20.MCA
Intact + 20.MICA
Castiates + 20.M1CA + oestradiol
Castrates + 20.M\(WA -- pituitary graft,
Castrates + 20.MNCA + oestradiol +-
progesterone
Lesion
Primary
In transmission
Primary
In transmission
Primary
In transmission
(syngeneic)
In transmission
(allogeneic)
Pirimairy
In traInsmission
Primary
In transmission
E.M. Observation
C I Ct. A Intra,-ci,st,. A 13 C
Not donie _ X-
-1
+ i1
mata (Haren-Ghera, 1967; Toth, 1963;
Irino, Ota and Sezaki, 1963; Ball and
McCarter, 1971) and radiation induced
lymphomata (Leiberman and Kaplan,
1959; Kaplan, 1967; Latarjet and Duplan,
1962) has been reported before. MuLV
from oestrogen induced lymphomata has
been successfully isolated for the first
time by Kunii, Takemoto and Furth
(1965). Earlier reports from this labora-
tory on the transmission of leukaemia
virus from the spontaneous lesions of
ICRC strain have shown that 12 out
of 18 acellular extracts tested could
transmit the disease in only 20-27%0
of syngeneic recipients with a long latent
period of 180-270 days. Attempts were
made to passage these lesions further.
However, these acellular extracts lost
the leukaemogenic activity during the
second and third passage (Ranadive et
al., 1973).
The results of the present series of
experiments have demonstrated successful
transmission of leukaemias induced by
carcinogen and hormones by acellular
extracts in syngeneic and allogeneic hosts.
Although the leukaemic lesions used in
these studies were originally induced in
the ovariectomized females, they were
transmissible not only to the intact
syngeneic females but to the syngeneic
male recipients as well. It was possible
to keep all the leukaemic extracts stuidied
in serial tranismission, except the one
prepared from leukaemic tissues of cas-
trated ICRC mice treated with carcinogen
alone. Low activity of the leukaemia
virus was demonstrated in primary pas-
sages; however, on serial animal passages
the oncogenicity of the agent was en-
hanced, with a reduction in latent period.
Similar biological behaviour of the leukae-
mogenic agent isolated from the radiation
induced leukaemia virus (Rad LV) has
been reported by Kaplan (1967).
During the serial passaging, difficulty
was experienced in the transmission of the
acellular extracts of the leukaemic tissues
from ovariectomized ICRC females treated
with carcinogen (extract II) as against
ovariectomized mice treated with carcino-
gen and hormones (extracts III, IV and
V). This lack of serial transmission of
leukaemogenic agent in the absence of
ovarian hormones indicates the specific
importance of hormonal factor in activat-
ing the agenit.
Present data have proved convincingly
the high potency ofthe virus in leukaemias
initiated by carcinogen and promoted by
oestradiol. The potency of the virus
was further enhanced by (i) preparing
4000 acellular extract in lieu of 250o
routinely used and (ii) by preparing high
centrifugal pellet. This leukaemic line
is in the 20th passage ofserial transmission
at present and the leukaemic tissues
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exhibit the consistent presence of intra-
cytoplasmic type A particles (supposed
to be the precursor of MTV type B
particles), with a complete absence of
type C particles, under the electron
microscope. The virus isolated from the
leukaemic tissues of these animals could
be transmitted to suckling mice ofvarious
allogeneic strains. It has been reported
that susceptibility to Gross leukaemia
virus in mice is influenced by two major
genes which are associated with H2-locus
(Lilly, 1970; McDevitt and Bodmer,
1972). The fact that the cell-free agent
can be successfully transmitted in the
other strains ofmice withentirelv different
histocompatibility genes demonstrates
that the transplantation of the leukaemo-
genic agent isolated from leukaemia in-
duced with carcinogen and oestradiol is
not dependent on H2-locus. The afore-
mentioned observations demonstrate the
importance of intracytoplasmic type A
particles in the induction of leukaemia in
strain ICRC.
The transmission of virus isolated
from leukaemic lesions of carcinogen and
oestradiol treated animals selectively in
MTV-free allogeneic hosts is a point worth
noting. Reciprocal interference of MTV
and MuLV has been reported in PS and
Balb/c mice (Mouriquand and Mouri-
quand, 1965; Squartini et al., 1967).
Leukaemia in the MTV-free line of ICRC,
developed by foster nursing the ICRC
suckling on MTV free strain C57-BL,
presents abundance of type C particles
(Vaidya, 1972), thereby supporting the
observations of Mouriquand and Mouri-
quand (1965) and Squartini et al. (1967).
The results in the ICRC mouse also
indicate direct interference between MTV
and MuLV.
The presence of intracytoplasmic type
A particles has been reported in hormone
dependent Leydig cell tumours (Pourreau-
Schneider, 1967) as well as plasma cell
tumours of mice (Dalton and Potter,
1968; Howatson and McCulloch, 1968).
Lately, intracytoplasmic type A particles
have been reported in the leukaemic
tissues of strain Balb/cf (RIII) (Squartini,
Bucciarelli and Bolis, 1972) and GR
(Hilgers et al., 1972). In the present
series of experiments, the consistent
abundance of exclusive intracytoplasmic
type A particles in leukaemias induced
by MCA and ovarian hormones, particu-
larly high doses of oestradiol, is a signifi-
cant observation. Besides type A parti-
cles, type B particles were also present
in the leukaemic tissues of mice treated
with oestradiol and progesterone. It is
therefore felt that the ovarian hormones
(oestradiol and progesterone) could pos-
sibly attack, stimulate and activate speci-
fically the virogene for MTV. The latest
results of Hilgers (1972) have shown that
the MTV antigens are present in the
reticuloendothelial tissues of almost all
the strains of mice studied. Since the
mammary gland in the ovariectomized
females receiving oestradiol alone is not
properly primed with necessary ovarian
hormones to offer replicating sites for
the MTV, the spleen and/or thymus could
provide replicating sites for MTV. Leukae-
mic lesions induced in these animals
exhibit an abundance of cytoplasmic A
particles. Oestradiol, in combination
with progesterone, seems to be more
effective in activating the MTV in the
mammary glands as was evident by
the early appearance of precancerous
nodules ultimately developing into mam-
mary tumours in this group. About
4500 of the total leukaemic mice in this
experimental group developed mammary
tumours as well.
The leukaemic lines exhibiting differ-
ences in the phenotypic expression of the
viral particles have been kept in serial
transmission. They can be used as an
ideal source of material for structural
and antigenic studies on leukaemic agents.
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